Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

Consumer sentiment fell in January for the first time in six months, according to U-M survey. What's next as Trump creates ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

Senator Rick Scott (R-FL) announced the reintroduction of his Protect Our Seniors Act, a legislative effort aimed at preserving and protecting Social Security ...

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...

The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

The Centers for Medicare and Medicaid Services (CMS) says about 8,247,000 people with Medicare Part D coverage use the ten drugs selected for price negotiation.